Cancer Keys: Chronic Myeloid Leukaemia and Fatigue

Latest from the Blog

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more
DRE and Prostate Cancer

DRE and Prostate Cancer

Friday 27th March 2020 A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA;...

read more

Related Posts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Potential pitfall:

Fatigue is a common presenting problem in primary care, and yet it is important to remember that fatigue can represent a more serious condition. Many patients with chronic myeloid leukaemia (CML) have few or no symptoms at the time they are diagnosed. Therefore, CML can be an incidental finding following a blood test as part of a routine check-up for fatigue, malaise or another condition.

Helpful hint:

NICE NG12 guidelines recommend GPs to consider a very urgent full blood count (within 48 hours) to assess for leukaemia in adults with any of the following: pallor, persistent fatigue, unexplained fever, unexplained persistent or recurrent infection, generalised lymphadenopathy, unexplained bruising, unexplained bleeding, unexplained petechiae and hepatosplenomegaly.

Please note: if the disease has progressed symptoms become more likely.

Cancer Keys are brought to you by GatewayC.

Download this Cancer Key here

Read the NICE NG12 guidance here

Access GatewayC’s Chronic Leukaemia – Early Diagnosis course here

LinkedIn Twitter | Facebook